NYSE:ANTM - Anthem Stock Price, Price Target & More

$226.07 -1.60 (-0.70 %)

(As of 04/22/2018 08:07 AM ET)

Previous Close$226.07

Today's Range$225.33 - $229.76

52-Week Range$166.50 - $267.95

Volume1.13 million shs

Average Volume1.47 million shs

Market Capitalization$57.81 billion

P/E Ratio18.85

Dividend Yield1.33%

Beta0.9

About Anthem (NYSE:ANTM)

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Receive ANTM News and Ratings via Email

Sign-up to receive the latest news and ratings for ANTM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans

Sub-IndustryManaged Health Care

SectorMedical

SymbolNYSE:ANTM

CUSIP94973V10

Webwww.antheminc.com

Phone317-488-6000

Debt

Debt-to-Equity Ratio0.66%

Current Ratio1.55%

Quick Ratio1.55%

Price-To-Earnings

Trailing P/E Ratio18.85

Forward P/E Ratio14.98

P/E Growth1.3

Sales & Book Value

Annual Sales$90.04 billion

Price / Sales0.64

Cash Flow$16.0220 per share

Price / Cash14.11

Book Value$103.22 per share

Price / Book2.19

Profitability

EPS (Most Recent Fiscal Year)$12.04

Net Income$3.84 billion

Net Margins4.27%

Return on Equity12.29%

Return on Assets4.67%

Miscellaneous

Employees56,000

Outstanding Shares255,720,000

How to Become a New Pot Stock Millionaire

Anthem (NYSE:ANTM) Frequently Asked Questions

What is Anthem's stock symbol?

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

How often does Anthem pay dividends? What is the dividend yield for Anthem?

Anthem announced a quarterly dividend on Wednesday, January 31st. Investors of record on Friday, March 9th will be paid a dividend of $0.75 per share on Friday, March 23rd. This represents a $3.00 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend is Thursday, March 8th. This is an increase from Anthem's previous quarterly dividend of $0.70. View Anthem's Dividend History.

How will Anthem's stock buyback program work?

Anthem announced that its board has authorized a share repurchase plan on Friday, December 8th 2017, which permits the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's management believes its shares are undervalued.

How were Anthem's earnings last quarter?

Anthem Inc (NYSE:ANTM) announced its earnings results on Wednesday, January, 31st. The company reported $1.29 EPS for the quarter, topping analysts' consensus estimates of $1.25 by $0.04. The firm earned $22.45 billion during the quarter, compared to analyst estimates of $22.17 billion. Anthem had a net margin of 4.27% and a return on equity of 12.29%. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.76 earnings per share. View Anthem's Earnings History.

When is Anthem's next earnings date?

Anthem is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Anthem.

What price target have analysts set for ANTM?

17 brokers have issued 1-year target prices for Anthem's stock. Their predictions range from $151.00 to $280.00. On average, they expect Anthem's share price to reach $235.00 in the next year. View Analyst Ratings for Anthem.

What are Wall Street analysts saying about Anthem stock?

Here are some recent quotes from research analysts about Anthem stock:

1. According to Zacks Investment Research, "Anthem's shares have outperformed the industry in the last six months. Its diverse product portfolio has helped in improving underwriting results. Its strategic acquisitions, divestitures and ACO arrangements pave the way for long-term growth. The company’s rising level of medical membership continues to boost the top line. Its strong capital position backs effective capital deployment via share buyback programs and regular dividend payments. The company has seen the Zacks Consensus Estinmate for 2018 earnings being revised upward in the last 60 days. However, loss incurred on public exchange business continues to bother. Also rising level of debt and expenses keep draining the margins. The company will release first quarter 2018 results on Apr 25 before the market opens." (4/10/2018)
2. Cantor Fitzgerald analysts commented, "This morning, Anthem announced that it will launch a new PBM, which will partner with CVS Health (CVS – Not Rated) for various services, including prescription fulfillment and claims processing services." (10/18/2017)

Who are some of Anthem's key competitors?

Some companies that are related to Anthem include Novo Nordisk (NVO), Amgen (AMGN), Medtronic (MDT), Abbott Laboratories (ABT), Bayer (BAYRY), Sanofi (SNY), GlaxoSmithKline (GSK), Gilead Sciences (GILD), AstraZeneca (AZN), Thermo Fisher Scientific (TMO), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), CSL (CSL), Celgene (CELG), GlaxoSmithKline (GSK), Becton Dickinson (BDX), Stryker (SYK) and Aetna (AET).

Who are Anthem's key executives?

Anthem's management team includes the folowing people:

Mr. Joseph R. Swedish, Exec. Chairman (Age 66)
Mr. John Edward Gallina, Exec. VP & CFO (Age 58)
Ms. Gloria Marie McCarthy, Exec. VP & Chief Admin. Officer (Age 65)
Mr. Peter D. Haytaian Esq., Exec. VP and Pres of the Gov. Bus. Division (Age 48)
Mr. Brian T. Griffin, Exec. VP and Pres of Commercial & Specialty Bus. Division (Age 59)

Has Anthem been receiving favorable news coverage?

Media coverage about ANTM stock has been trending somewhat positive on Sunday, according to Accern Sentiment. The research group identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Anthem earned a media sentiment score of 0.07 on Accern's scale. They also assigned news stories about the company an impact score of 46.49 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of Anthem?

Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Anthem's stock price today?

One share of ANTM stock can currently be purchased for approximately $226.07.

How big of a company is Anthem?

Anthem has a market capitalization of $57.81 billion and generates $90.04 billion in revenue each year. The company earns $3.84 billion in net income (profit) each year or $12.04 on an earnings per share basis. Anthem employs 56,000 workers across the globe.

How can I contact Anthem?

Anthem's mailing address is 120 MONUMENT CIRCLE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 317-488-6000 or via email at [email protected]

MarketBeat Community Rating for Anthem (ANTM)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		509 (Vote Outperform)
Underperform Votes:		547 (Vote Underperform)
Total Votes:		1,056

MarketBeat's community ratings are surveys of what our community members think about Anthem and other stocks. Vote "Outperform" if you believe ANTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANTM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Anthem (NYSE:ANTM) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

17 Wall Street analysts have issued ratings and price targets for Anthem in the last 12 months. Their average twelve-month price target is $235.00, suggesting that the stock has a possible upside of 3.95%. The high price target for ANTM is $280.00 and the low price target for ANTM is $151.00. There are currently 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.76	2.76	2.71	2.56
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$235.00	$235.00	$206.1429	$190.1875
Price Target Upside:	3.95% upside	1.35% upside	17.43% downside	1.56% upside

Anthem (NYSE:ANTM) Consensus Price Target History

Price Target History for Anthem (NYSE:ANTM)

Anthem (NYSE:ANTM) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/8/2018	Barclays	Initiated Coverage	Overweight -> Overweight	$270.00	High
2/1/2018	Credit Suisse Group	Reiterated Rating	Outperform	$255.00 -> $280.00	Low
2/1/2018	Morgan Stanley	Boost Price Target	Equal Weight -> Equal Weight	$247.00 -> $266.00	Low
2/1/2018	Wells Fargo	Boost Price Target	Outperform -> Outperform	$260.00 -> $275.00	Medium
1/31/2018	Cowen	Reiterated Rating	Buy	$280.00	Low
1/19/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$275.00	Low
1/12/2018	Jefferies Group	Upgrade	Hold -> Buy	$235.00 -> $211.00	High
1/4/2018	Royal Bank of Canada	Reiterated Rating	Buy		Medium
1/3/2018	Goldman Sachs	Initiated Coverage	Neutral -> Neutral	$243.00	Medium
1/3/2018	Piper Jaffray	Upgrade	Neutral -> Overweight	$151.00	Medium
12/6/2017	B. Riley	Reiterated Rating	Buy -> Buy		Low
11/17/2017	Bank of America	Boost Price Target	Buy	$249.00 -> $254.00	N/A
11/7/2017	Leerink Swann	Reiterated Rating	Outperform		N/A
10/16/2017	BMO Capital Markets	Initiated Coverage	Market Perform		N/A
7/13/2017	Deutsche Bank	Boost Price Target	Hold	$173.00 -> $185.00	Low
6/28/2017	Citigroup	Reiterated Rating	Buy	$205.00	Low
4/28/2017	Sanford C. Bernstein	Boost Price Target	Outperform	$202.00 -> $212.00	Low
3/16/2017	UBS	Reiterated Rating	Buy	$189.00	N/A
1/4/2017	Stifel Nicolaus	Downgrade	Buy -> Hold	$143.24 -> $155.00	N/A
11/22/2016	Wolfe Research	Upgrade	Market Perform -> Outperform	$173.00	N/A
10/17/2016	JPMorgan Chase	Downgrade	Overweight -> Neutral	$154.00 -> $132.00	N/A
9/22/2016	Evercore ISI	Initiated Coverage	Hold	$133.00	N/A
8/15/2016	FBR & Co	Reiterated Rating	Market Perform	$155.00	N/A
7/27/2016	Wedbush	Reiterated Rating	Neutral	$150.00	N/A
5/24/2016	Sterne Agee CRT	Downgrade	Buy -> Neutral		N/A
4/28/2016	Oppenheimer	Reiterated Rating	Buy		N/A

(Data available from 4/22/2016 forward)

Anthem (NYSE:ANTM) Earnings History and Estimates Chart

Earnings by Quarter for Anthem (NYSE:ANTM)

Anthem (NYSE:ANTM) Earnings Estimates

2018 EPS Consensus Estimate: $15.13

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$4.67	$4.75	$4.71
Q2 2018	2	$4.49	$4.57	$4.53
Q3 2018	2	$3.37	$3.58	$3.48
Q4 2018	2	$2.40	$2.43	$2.42

Anthem (NYSE ANTM) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/25/2018							N/A
1/31/2018	Q4 2017	$1.25	$1.29	$22.1660 billion	$22.4470 billion	View	Listen
10/25/2017	Q3 2017	$2.40	$2.65	$22.1005 billion	$22.0967 billion	View	N/A
7/26/2017	Q2 2017	$3.23	$3.37	$22.2530 billion	$22.1980 billion	View	N/A
4/26/2017	Q1 2017	$3.85	$4.68	$21.2347 billion	$22.3195 billion	View	N/A
2/1/2017	Q416	$1.61	$1.76	$20.96 billion	$21.50 billion	View	Listen
11/2/2016	Q316	$2.47	$2.45	$20.77 billion	$21.13 billion	View	Listen
7/27/2016	Q216	$3.23	$3.33	$20.53 billion	$21.27 billion	View	Listen
4/27/2016	Q116	$3.32	$3.46	$19.86 billion	$20.30 billion	View	Listen
1/27/2016	Q415	$1.20	$1.14	$19.8860 billion	$20.02 billion	View	Listen
10/28/2015	Q315	$2.33	$2.73	$19.63 billion	$19.77 billion	View	Listen
7/29/2015	Q215	$2.75	$3.10	$19.64 billion	$19.80 billion	View	Listen
4/29/2015	Q115	$2.69	$3.14	$19.36 billion	$18.8510 billion	View	Listen
1/28/2015	Q414	$1.72	$1.73	$18.99 billion	$18.78 billion	View	Listen
10/29/2014	Q314	$2.28	$2.36	$18.72 billion	$18.40 billion	View	Listen
7/30/2014	Q214	$2.28	$2.44	$18.25 billion	$18.23 billion	View	Listen
4/30/2014	Q114	$2.12	$2.30	$17.96 billion	$17.65 billion	View	Listen
1/29/2014	Q413	$0.87	$0.87	$17.75 billion	$17.60 billion	View	Listen
10/23/2013	Q313	$1.79	$2.10	$17.63 billion	$17.70 billion	View	Listen
7/24/2013	Q2 2013	$2.09	$2.60	$17.89 billion	$17.60 billion	View	Listen
4/24/2013	Q1 2013	$2.38	$2.94	$18.03 billion	$17.55 billion	View	Listen
1/23/2013	Q4 2012	$0.94	$1.03	$15.23 billion	$15.54 billion	View	Listen
11/7/2012	Q312	$1.84	$2.09	$15.3084 billion	$15.1330 billion	View	N/A
7/25/2012		$2.07	$2.04			View	N/A
4/25/2012		$2.26	$2.34			View	N/A
1/25/2012		$1.12	$0.99			View	N/A
10/26/2011		$1.68	$1.77			View	N/A
7/27/2011		$1.80	$1.83			View	N/A
4/27/2011		$1.87	$2.35			View	N/A
1/26/2011		$1.23	$1.33			View	N/A
11/3/2010	Q3 2010	$1.58	$1.74			View	N/A
7/28/2010	Q2 2010	$1.56	$1.67			View	N/A
4/28/2010	Q1 2010	$1.66	$1.95			View	N/A
1/27/2010	Q4 2009	$1.02	$1.16			View	N/A
10/28/2009	Q3 2009	$1.39	$1.78			View	N/A
7/29/2009	Q2 2009	$1.43	$1.43			View	N/A
4/22/2009	Q1 2009	$1.26	$1.62			View	N/A
1/28/2009	Q4 2008	$1.32	$1.34			View	N/A
10/22/2008	Q3 2008	$1.51	$1.58			View	N/A
7/23/2008	Q2 2008	$1.36	$1.44			View	N/A
4/23/2008	Q1 2008	$1.18	$1.13			View	N/A
1/23/2008	Q4 2007	$1.51	$1.51			View	N/A

(Earnings results data provided by Zacks Investment Research)

Anthem (NYSE:ANTM) Dividend Information

Anthem pays an annual dividend of $3.00 per share, with a dividend yield of 1.33%. ANTM's most recent quarterly dividend payment was Friday, March 23. The company has grown its dividend for the last 3 consecutive years and is increasing its dividend by an average of 83.40% each year. Anthem pays out 24.92% of its earnings out as a dividend.

Most Recent Dividend:	3/23/2018
Annual Dividend:	$3.00
Dividend Yield:	1.33%
Dividend Growth:	83.40% (3 Year Average)
Payout Ratio:	24.92% (Trailing 12 Months of Earnings) 19.88% (Based on This Year's Estimates) 18.07% (Based on Next Year's Estimates)
Track Record:	3 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Anthem (NYSE:ANTM)

Anthem (NYSE:ANTM) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/31/2018	quarterly	$0.75	1.37%	3/8/2018	3/9/2018	3/23/2018
10/26/2017	quarterly	$0.70	1.35%	12/4/2017	12/5/2017	12/21/2017
7/26/2017	quarterly	$0.70	1.54%	9/7/2017	9/8/2017	9/25/2017
4/27/2017	quarterly	$0.65	1.46%	6/7/2017	6/9/2017	6/23/2017
2/22/2017	quarterly	$0.65	1.59%	3/8/2017	3/10/2017	3/24/2017
11/2/2016	quarterly	$0.65	2.11%	12/1/2016	12/5/2016	12/21/2016
7/27/2016	quarterly	$0.65	1.96%	9/7/2016	9/9/2016	9/26/2016
4/27/2016	quarterly	$0.65	1.8%	6/8/2016	6/10/2016	6/24/2016
2/18/2016	quarterly	$0.65	2.04%	3/8/2016	3/10/2016	3/25/2016
10/28/2015	quarterly	$0.6250	1.77%	12/2/2015	12/4/2015	12/21/2015
7/28/2015		$0.6250		9/8/2015	9/10/2015	9/25/2015
7/29/2015	quarterly	$0.6250	1.61%	9/8/2015	9/10/2015	9/25/2015
4/29/2015	quarterly	$0.6250	1.65%	6/8/2015	6/10/2015	6/25/2015
1/27/2015		$0.6250		3/6/2015	3/10/2015	3/25/2015
1/29/2015	quarterly	$0.6250	1.82%	3/6/2015	3/10/2015	3/25/2015
10/29/2014	quarterly	$0.4375		12/3/2014	12/5/2014	12/22/2014
7/30/2014	quarterly	$0.4375	1.59%	9/8/2014	9/10/2014	9/25/2014
5/1/2014	quarterly	$0.4375	1.74%	6/6/2014	6/10/2014	6/25/2014
1/29/2014	quarterly	$0.4375	1.99%	3/6/2014	3/10/2014	3/25/2014
10/23/2013	quarterly	$0.3750	1.79%	12/5/2013	12/9/2013	12/23/2013
7/24/2013	quarterly	$0.3750	1.75%	9/6/2013	9/10/2013	9/25/2013
5/15/2013	quarterly	$0.3750	1.95%	6/6/2013	6/10/2013	6/25/2013
2/21/2013	quarterly	$0.3750	2.42%	3/6/2013	3/8/2013	3/25/2013

(Data available from 1/1/2013 forward)

Anthem (NYSE ANTM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.31%
Institutional Ownership Percentage: 88.27%

Insider Trading History for Anthem (NYSE:ANTM)

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Anthem (NYSE ANTM) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2018	Thomas C Zielinski	EVP	Sell	20,455	$229.23	$4,688,899.65
3/7/2018	Ronald W Penczek	SVP	Sell	1,966	$231.90	$455,915.40	2,132
3/5/2018	John E Gallina	CFO	Sell	24,576	$229.81	$5,647,810.56	22,139
3/5/2018	Joseph Swedish	Insider	Sell	27,846	$231.12	$6,435,767.52	84,545
2/1/2018	Joseph Swedish	Insider	Sell	64,403	$244.37	$15,738,161.11	84,346
1/11/2018	Joseph Swedish	Insider	Sell	67,500	$235.87	$15,921,225.00	134,043
1/4/2018	Gloria M Mccarthy	EVP	Sell	14,429	$229.68	$3,314,052.72	30,667
12/1/2017	Joseph Swedish	Chairman	Sell	21,125	$231.43	$4,888,958.75	87,668
11/7/2017	Julie A Hill	Director	Sell	1,602	$215.70	$345,551.40	35,322
11/7/2017	Ronald W Penczek	SVP	Sell	978	$217.42	$212,636.76	1,222
11/1/2017	Joseph Swedish	Insider	Sell	21,125	$209.85	$4,433,081.25	87,668
10/2/2017	Joseph Swedish	Insider	Sell	21,125	$190.63	$4,027,058.75
9/1/2017	Joseph Swedish	Insider	Sell	21,125	$197.00	$4,161,625.00	87,668
8/10/2017	Julie A Hill	Director	Sell	524	$190.80	$99,979.20	36,924
8/10/2017	Thomas C Zielinski	EVP	Sell	9,127	$191.25	$1,745,538.75	26,571
6/7/2017	Ronald W Penczek	SVP	Sell	867	$187.46	$162,527.82	1,872
5/30/2017	Ramiro G Peru	Director	Sell	2,681	$181.58	$486,815.98	13,571
5/24/2017	Julie A Hill	Director	Sell	555	$180.56	$100,210.80	37,448
4/3/2017	Gloria M Mccarthy	EVP	Sell	15,187	$166.38	$2,526,813.06	59,144
3/6/2017	Ronald W Penczek	SVP	Sell	729	$165.56	$120,693.24	1,448
3/2/2017	Ronald W Penczek	SVP	Sell	1,213	$166.56	$202,037.28	1,248
3/2/2017	Thomas C Zielinski	EVP	Sell	22,936	$166.29	$3,814,027.44	17,376
1/9/2017	Jose D Tomas	EVP	Sell	6,500	$142.92	$928,980.00	23,913
12/12/2016	Joseph Swedish	Insider	Sell	8,176	$144.10	$1,178,161.60	75,601
11/22/2016	Ronald W Penczek	SVP	Sell	820	$138.29	$113,397.80	1,320
11/11/2016	Joseph Swedish	Insider	Sell	24,513	$131.48	$3,222,969.24	87,381
8/10/2016	Thomas C Zielinski	EVP	Sell	5,254	$128.83	$676,872.82	17,935
8/3/2016	Ronald W Penczek	SVP	Sell	552	$128.37	$70,860.24	2,407
8/1/2016	Gloria M Mccarthy	EVP	Sell	4,186	$130.39	$545,812.54	49,426
7/28/2016	William J Ryan	Director	Sell	3,125	$133.15	$416,093.75	27,149
7/11/2016	Joseph Swedish	CEO	Sell	8,171	$131.49	$1,074,404.79	112,594
7/1/2016	Gloria M Mccarthy	EVP	Sell	4,786	$131.23	$628,066.78	46,167
6/29/2016	Ramiro G Peru	Director	Sell	3,125	$130.00	$406,250.00	15,262
6/1/2016	Gloria M Mccarthy	EVP	Sell	4,786	$131.69	$630,268.34	48,326
6/1/2016	Joseph Swedish	CEO	Sell	11,628	$132.02	$1,535,128.56	124,694
5/2/2016	Gloria M Mccarthy	EVP	Sell	4,786	$141.02	$674,921.72	48,477
5/2/2016	Joseph Swedish	CEO	Sell	11,626	$141.19	$1,641,474.94	137,648
4/14/2016	Gloria M Mccarthy	EVP	Sell	4,786	$142.26	$680,856.36	51,081
4/1/2016	Joseph Swedish	CEO	Sell	11,626	$139.38	$1,620,431.88	169,535
3/11/2016	Gloria M Mccarthy	EVP	Sell	7,557	$139.73	$1,055,939.61	46,295
1/28/2016	Joseph Swedish	CEO	Sell	11,626	$129.47	$1,505,218.22	182,602
12/28/2015	Joseph Swedish	CEO	Sell	11,626	$139.47	$1,621,478.22	194,228
9/8/2015	Wayne S. Deveydt	CFO	Sell	6,969	$144.00	$1,003,536.00	69,607
6/1/2015	Ramiro G Peru	Director	Sell	4,709	$167.91	$790,688.19
5/28/2015	William J Ryan	Director	Sell	4,709	$163.58	$770,298.22
4/13/2015	Gloria M Mccarthy	EVP	Sell	43,933	$155.02	$6,810,493.66
3/3/2015	John E Gallina	CAO	Sell	39,556	$145.30	$5,747,486.80
12/8/2014	Wayne S Deveydt	CFO	Sell	4,404	$127.72	$562,478.88
10/13/2014	Wayne S Deveydt	CFO	Sell	26,938	$116.71	$3,143,933.98
9/18/2014	Kenneth R Goulet	EVP	Sell	41,624	$121.32	$5,049,823.68
9/11/2014	Samuel R Md Nussbaum	EVP	Sell	20,000	$120.00	$2,400,000.00
9/9/2014	Samuel R Md Nussbaum	EVP	Sell	38,244	$119.52	$4,570,922.88
9/9/2014	Wayne S Deveydt	CFO	Sell	4,404	$120.00	$528,480.00
9/8/2014	Wayne S Deveydt	CFO	Sell	64,536	$118.00	$7,615,248.00
8/28/2014	Samuel R Md Nussbaum	EVP	Sell	40,000	$116.05	$4,642,000.00
8/27/2014	Samuel R Md Nussbaum	EVP	Sell	35,000	$116.06	$4,062,100.00
8/5/2014	Wayne S Deveydt	CFO	Sell	30,000	$110.95	$3,328,500.00
1/31/2014	George Schaefer, Jr.	Director	Sell	10,000	$86.70	$867,000.00	33,055
12/26/2013	Richard Zoretic	EVP	Sell	20,000	$91.79	$1,835,800.00	24,432
12/13/2013	John Cannon	EVP	Sell	9,558	$87.73	$838,523.34	99,331
12/11/2013	Gloria Mccarthy	EVP	Sell	111,867	$90.99	$10,178,778.33	57,259
9/13/2013	Samuel Md Nussbaum	EVP	Sell	117,512	$89.20	$10,482,070.40	91,463
9/11/2013	Samuel Md Nussbaum	EVP	Sell	42,100	$89.29	$3,759,109.00	91,463
9/10/2013	John Cannon	EVP	Sell	13,799	$87.33	$1,205,066.67
9/5/2013	Wayne S Deveydt	CFO	Sell	165,576	$87.54	$14,494,523.04
9/4/2013	Randal L Brown	EVP	Sell	223,647	$86.86	$19,425,978.42
8/26/2013	Warren Jobe	Director	Sell	3,000	$86.56	$259,680.00	30,525
8/14/2013	John Cannon	EVP	Sell	114,336	$86.95	$9,941,515.20	116,748
8/6/2013	Kenneth Goulet	EVP	Sell	62,643	$87.36	$5,472,492.48	72,472
6/10/2013	John Cannon	EVP	Sell	97,759	$78.27	$7,651,596.93
6/5/2013	William J Ryan	Director	Sell	10,000	$75.23	$752,300.00
5/30/2013	Lori A Beer	EVP	Sell	131,312	$78.91	$10,361,829.92
5/30/2013	Warren Y Jobe	Director	Sell	3,000	$78.01	$234,030.00
5/28/2013	Lori A Beer	EVP	Sell	55,732	$79.00	$4,402,828.00
5/22/2013	Gloria M Mccarthy	CAO	Sell	33,919	$78.71	$2,669,764.49
2/25/2013	George A Schaefer Jr	Director	Sell	7,542	$62.12	$468,509.04

(Data available from 1/1/2013 forward)

Anthem (NYSE ANTM) News Headlines

Source:

Date	Headline
	Anticipating Anthem Protests, Spain Braces for 'Verbal Violence' www.nytimes.com - April 19 at 4:39 PM
	Anthem (ANTM) Now Covered by Credit Suisse Group www.americanbankingnews.com - April 18 at 9:10 PM
	John Amirante, Longtime Anthem Singer for the Rangers, Dies at 83 www.nytimes.com - April 18 at 9:54 AM
	Anthem (ANTM) Scheduled to Post Earnings on Wednesday www.americanbankingnews.com - April 18 at 1:18 AM
	Anthem Blue Cross and Blue Shield in Missouri Introduces New Medicare Supplement Plan F to Help Consumers ... www.businesswire.com - April 17 at 9:43 AM
	Rachel Platten on 'embarrassing' national anthem debacle: 'My mind just went blank' www.foxnews.com - April 17 at 9:43 AM
	Leerink Swann Equities Analysts Cut Earnings Estimates for Anthem Inc (ANTM) www.americanbankingnews.com - April 17 at 6:13 AM
	Colin Kaepernick Invokes Jackie Robinson's 'I Cannot Stand' For Anthem www.huffingtonpost.com - April 16 at 4:29 PM
	Earnings Expectations for UnitedHealth Group in 1Q18 finance.yahoo.com - April 16 at 4:29 PM
	Kaepernick shares Jackie Robinson anthem quote www.usatoday.com - April 16 at 9:45 AM
	Colin Kaepernick tweets Jackie Robinson quote on national anthem www.usatoday.com - April 16 at 9:45 AM
	Anthem Inc Forecasted to Post Q1 2018 Earnings of $4.67 Per Share (ANTM) www.americanbankingnews.com - April 16 at 1:44 AM
	Anthem (ANTM) Downgraded to Hold at BidaskClub www.americanbankingnews.com - April 15 at 12:36 AM
	Missing Man Went Overboard on Anthem of the Seas Cruise Ship, Coast Guard Says fortune.com - April 14 at 5:43 PM
	MLB's Bruce Maxwell, who knelt during anthem, pleads guilty to disorderly conduct after gun charge www.foxnews.com - April 14 at 9:39 AM
	Woman declines to sing national anthem at minor league game because she can't bring her gun www.foxnews.com - April 14 at 9:39 AM
	Bengals tackle anthem kneeling issue with free agent www.bizjournals.com - April 13 at 4:27 PM
	The Seahawks reportedly 'postponed' a meeting with Colin Kaepernick after he said he wouldn't stop kneeling during the national anthem www.businessinsider.com - April 13 at 9:53 AM
	No guns? No anthem, singer tells Reno minor-league baseball team www.msn.com - April 13 at 9:53 AM
	Brokers Issue Forecasts for Anthem Inc's Q2 2018 Earnings (ANTM) www.americanbankingnews.com - April 13 at 8:51 AM
	No guns allowed? No national anthem from me, singer tells Reno baseball team www.latimes.com - April 12 at 10:25 AM
	Zacks: Analysts Expect Anthem Inc (ANTM) Will Announce Quarterly Sales of $22.66 Billion www.americanbankingnews.com - April 12 at 5:09 AM
	Anthem Inc (ANTM) Given Average Rating of "Buy" by Analysts www.americanbankingnews.com - April 11 at 8:51 AM
	Zacks Investment Research Lowers Anthem (ANTM) to Hold www.americanbankingnews.com - April 10 at 2:51 PM
	Anthem Inc (ANTM) Expected to Post Earnings of $5.07 Per Share www.americanbankingnews.com - April 10 at 1:07 AM
	Anthem (ANTM) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - April 9 at 1:55 PM
	Anthem (ANTM) Earns "Hold" Rating from Piper Jaffray www.americanbankingnews.com - April 7 at 11:00 PM
	Anthem's (ANTM) Buy Rating Reiterated at Cantor Fitzgerald www.americanbankingnews.com - April 6 at 3:32 PM
	The eagle has landed -- on a baseball player during the national anthem abcnews.go.com - April 6 at 10:02 AM
	[$$] Anthem May Win by Sitting Out Wave of Health Insurance Deals finance.yahoo.com - April 6 at 10:02 AM
	Anthem to Hold Conference Call and Webcast to Discuss First Quarter Results on April 25, 2018 finance.yahoo.com - April 5 at 4:22 PM
	Cantor Fitzgerald Reaffirms "Buy" Rating for Anthem (ANTM) www.americanbankingnews.com - April 5 at 2:17 PM
	Anthem (ANTM) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - April 4 at 11:58 PM
	Anthem (ANTM) Price Target Raised to $215.00 www.americanbankingnews.com - April 4 at 7:30 PM
	Cliffside Malibu's Sherman Oaks Facility Now In Network With Anthem Blue Cross www.prnewswire.com - April 4 at 5:03 PM
	Gov. Deal directs Blue Cross, Piedmont back to negotiations www.bizjournals.com - April 4 at 5:03 PM
	Medicare Rate Up More than Expected, Health Insurers to Gain finance.yahoo.com - April 4 at 5:03 PM
	Cook on Apple campus site selection: Not a 'beauty contest' finance.yahoo.com - April 3 at 4:31 PM
	Anthem (ANTM) Downgraded by Zacks Investment Research to Hold www.americanbankingnews.com - April 3 at 2:58 PM
	Students Singing National Anthem Kneel At MLB Game www.huffingtonpost.com - April 2 at 4:35 PM
	Students kneel while performing anthem at MLB game www.usatoday.com - April 2 at 10:17 AM
	Anthem, Piedmont Healthcare dispute threatens health care for thousands of Georgians www.bizjournals.com - April 2 at 10:17 AM
	Anthem deal tops Garland's 2017 www.bizjournals.com - April 1 at 9:38 AM
	ValuEngine Upgrades Anthem (ANTM) to Buy www.americanbankingnews.com - March 31 at 3:48 PM
	Anthem (ANTM) Cut to "Hold" at Zacks Investment Research www.americanbankingnews.com - March 31 at 1:12 PM
	Anthem (ANTM) Upgraded to Overweight at Piper Jaffray www.americanbankingnews.com - March 31 at 12:12 AM
	Anthem (ANTM) Earns Neutral Rating from Analysts at Goldman Sachs www.americanbankingnews.com - March 30 at 11:42 PM
	Anthem (ANTM) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - March 30 at 9:28 PM
	[$$] Walmart-Humana Talks Put Pressure on Remaining Health-Care Players finance.yahoo.com - March 30 at 4:26 PM
	'Love, Simon' Star Keiynan Lonsdale Releases A Heartfelt Queer Anthem www.huffingtonpost.com - March 30 at 9:38 AM